1. PB2115: TRIAL IN PROGRESS: A RANDOMIZED PHASE II STUDY OF MB-CART2019.1 COMPARED TO STANDARD OF CARE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION. (23rd June 2022) Authors: Borchmann, P.; Vandenberghe, P.; Urbano, A.; Haioun, C.; Lemonnier, F.; Griškevicius, L.; Maury, S.; Holtkamp, S.; Friedrichs, B.; Zadoyan, G.; Hanssens, L.; Brillant, C.; Bethke, U.; Assenmacher, M.; Bürger, I.; Philippe, B.; Overstijns, T.; Jäger, U.; Kersten, M. J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1986 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗